Page last updated: 2024-10-24

busulfan and Hemophilia A

busulfan has been researched along with Hemophilia A in 3 studies

Hemophilia A: The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Merlin, S1
Akula, S1
Cottonaro, A1
Garcia-Leal, T1
Serrano, LJ1
Borroni, E1
Kalandadze, V1
Galiano, R1
Borsotti, C1
Liras, A1
Sanchez, MJ1
Follenzi, A1
Moayeri, M1
Hawley, TS1
Hawley, RG1
Ide, LM1
Gangadharan, B1
Chiang, KY1
Doering, CB1
Spencer, HT1

Other Studies

3 other studies available for busulfan and Hemophilia A

ArticleYear
Therapeutic potential of fetal liver cell transplantation in hemophilia A mice.
    Haematologica, 2023, 06-01, Volume: 108, Issue:6

    Topics: Animals; Busulfan; Endothelial Cells; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Ce

2023
Correction of murine hemophilia A by hematopoietic stem cell gene therapy.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2005, Volume: 12, Issue:6

    Topics: Animals; Blotting, Northern; Blotting, Southern; Blotting, Western; Bone Marrow Cells; Bone Marrow T

2005
Hematopoietic stem-cell gene therapy of hemophilia A incorporating a porcine factor VIII transgene and nonmyeloablative conditioning regimens.
    Blood, 2007, Oct-15, Volume: 110, Issue:8

    Topics: Animals; Antineoplastic Agents; Busulfan; Cyclophosphamide; Factor VIII; Genetic Therapy; Hematopoie

2007